Open AccessEngaging Law Enforcement in Overdose Reversal Initiatives: Authorization and Liability for Naloxone Administration
Author(s) -
Corey S. Davis,
Derek Carr,
Jessica Southwell,
Leo Beletsky
Publication year - 2015
Publication title -
american journal of public health
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.284
H-Index - 264
eISSN - 1541-0048
pISSN - 0090-0036
DOI - 10.2105/ajph.2015.302638
Subject(s) - (+) naloxone , opioid overdose , administration (probate law) , law enforcement , medicine , officer , agency (philosophy) , liability , business , medical emergency , opioid , law , political science , finance , philosophy , receptor , epistemology
Opioid overdose is reversible through the timely administration of naloxone, which has been used by emergency medical services for decades. Law enforcement officers (LEOs) are often the first emergency responders to arrive at an overdose, but they are not typically equipped with naloxone. This is rapidly changing; more than 220 law enforcement agencies in 24 states now carry naloxone. However, rollout in some departments has been hampered by concerns regarding officer and agency liability. We systematically examined the legal risk associated with LEO naloxone administration. LEOs can be authorized to administer naloxone through a variety of mechanisms, and liability risks related to naloxone administration are similar to or lower than those of other activities in which LEOs commonly engage.